GlassScriptPhysician profile
James G Redmann
NPI 1235119439
$20,616.75
in general payments reported to CMS, 2019-2025
33 companies · $1,400 in 2025
The $1,400 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,258 · 2020: $224 · 2021: $6,629 · 2022: $9,389 · 2023: $783 · 2024: $934 · 2025: $1,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,727 · Travel and Lodging: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,727.43 |
| Travel and Lodging | $389.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asensus Surgical, INC. | $13,366.38 | 2019-2022 | |
| Intuitive Surgical, INC. | $2,803.02 | 2019-2023 | Da Vinci Surgical System |
| Enterra Medical, INC. | $998.08 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $754.61 | 2020-2025 | Gattex |
| Novo Nordisk INC | $334.76 | 2019-2024 | Wegovy, Saxenda |
| Baxter Healthcare | $327.61 | 2020-2024 | Tisseel |
| Becton, Dickinson and Company | $290.00 | 2021 | |
| Medtronic, INC. | $282.98 | 2024 | Signia, Ta |
| Kvk-Tech, INC. | $164.79 | 2019-2025 | |
| Intra-Sana Laboratories | $164.56 | 2024-2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Ethicon US, LLC | $159.24 | 2019 | |
| Lilly USA, LLC | $156.59 | 2024-2025 | Zepbound, Mounjaro |
| Echosens North America, INC. | $116.00 | 2023 | Fibroscan |
| Galderma Laboratories, L.P. | $109.84 | 2024 | |
| Redhill Biopharma INC. | $100.73 | 2021-2023 | Talicia |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $71.40 | 2019 | |
| Currax Pharmaceuticals LLC | $66.71 | 2021-2022 | |
| Stryker Corporation | $51.56 | 2019 | |
| Hologic Sales and Service, LLC | $39.15 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $36.77 | 2024-2025 | |
| Smith+Nephew, INC. | $35.93 | 2025 | Stravix Pl |
| Davol INC. | $26.38 | 2020 | |
| Innovation Technologies INC | $24.28 | 2025 | Irrisept |
| Convatec INC. | $21.97 | 2022 | |
| Endo Pharmaceuticals INC. | $18.39 | 2020 | |
| Tela Bio, INC. | $15.21 | 2024 | Ovitex 2s |
| Heron Therapeutics, INC. | $15.15 | 2023 | Zynrelef |
| Abbvie INC. | $14.23 | 2024 | |
| Pfizer INC. | $14.07 | 2022 | |
| Innocoll Pharmaceuticals Limited | $13.02 | 2021 | |
| Avanos Medical | $12.05 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $11.29 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Redmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.